Iris Rosenburgh

Iris Rosenburgh is an Investment Analyst at BVF PARTNERS, L.P, based in San Francisco, California. In her current role, she focuses on identifying, evaluating, and monitoring investments in the biotechnology sector, aligning with BVF’s specialization in public biotechnology equities and small-cap life sciences companies.

Before joining BVF PARTNERS, L.P. in 2023, Iris completed her PhD in Pharmacology at Yale University, conducting research in the Lemmon and Politi Labs, and held leadership roles in partnerships and strategy at Nucleate, a prominent nonprofit focused on life sciences innovation. Her experience bridges scientific research and strategic business evaluation, providing a broad perspective on biotechnology investments.

Iris holds a Bachelor of Arts in Natural Sciences (Pharmacology) from the University of Cambridge and a Doctor of Philosophy in Pharmacology from Yale. She has also participated in business coursework at the Yale School of Management, strengthening her expertise at the intersection of drug development, healthcare innovation, and financial analysis. Her background enables her to assess complex scientific assets and contribute to rigorous due diligence for biotech investments.